219 related articles for article (PubMed ID: 14971893)
1. Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.
Martínez V; Burgos C; Alvarez-Builla J; Fernández G; Domingo A; García-Nieto R; Gago F; Manzanares I; Cuevas C; Vaquero JJ
J Med Chem; 2004 Feb; 47(5):1136-48. PubMed ID: 14971893
[TBL] [Abstract][Full Text] [Related]
2. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
3. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
[TBL] [Abstract][Full Text] [Related]
5. Novel antitumor agent family of 1H-benzo[c,d]indol-2-one with flexible basic side chains: synthesis and biological evaluation.
Yin H; Xu Y; Qian X
Bioorg Med Chem; 2007 Feb; 15(3):1356-62. PubMed ID: 17129733
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activity of a new potential DNA bisintercalator: 1,4-Bis{3-[N-(4-chlorobenzo[g]phthalazin-1-yl)aminopropyl]}piperazine.
Galisteo J; Navarro P; Campayo L; Yunta MJ; Gómez-Contreras F; Villa-Pulgarin JA; Sierra BG; Mollinedo F; Gonzalez J; Garcia-España E
Bioorg Med Chem; 2010 Jul; 18(14):5301-9. PubMed ID: 20538470
[TBL] [Abstract][Full Text] [Related]
7. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
Baviskar AT; Madaan C; Preet R; Mohapatra P; Jain V; Agarwal A; Guchhait SK; Kundu CN; Banerjee UC; Bharatam PV
J Med Chem; 2011 Jul; 54(14):5013-30. PubMed ID: 21644529
[TBL] [Abstract][Full Text] [Related]
8. Functionalized and [a]-anellated carbazoles as potential B-DNA ligands: experimental studies of DNA binding and molecular modeling of intercalation complexes.
Pindur U; Marotto A; Schulze E; Fischer G
Pharmazie; 2000 Oct; 55(10):727-32. PubMed ID: 11082831
[TBL] [Abstract][Full Text] [Related]
9. Novel DNA intercalators without basic side chains as efficient antitumor agents: design, synthesis and evaluation of benzo-[c,d]-indol-malononitrile derivatives.
Li X; Wang Q; Qing Y; Lin Y; Zhang Y; Qian X; Cui J
Bioorg Med Chem; 2010 May; 18(9):3279-84. PubMed ID: 20385497
[TBL] [Abstract][Full Text] [Related]
10. Novel imidazo[1,2-a]naphthyridinic systems (part 1): synthesis, antiproliferative and DNA-intercalating activities.
Andaloussi M; Moreau E; Masurier N; Lacroix J; Gaudreault RC; Chezal JM; El Laghdach A; Canitrot D; Debiton E; Teulade JC; Chavignon O
Eur J Med Chem; 2008 Nov; 43(11):2505-17. PubMed ID: 18403058
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.
Nagarajan M; Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
J Med Chem; 2003 Dec; 46(26):5712-24. PubMed ID: 14667224
[TBL] [Abstract][Full Text] [Related]
12. DNA binding to guide the development of tetrahydroindeno[1,2-b]pyrido[4,3,2-de]quinoline derivatives as cytotoxic agents.
Catoen-Chackal S; Facompré M; Houssin R; Pommery N; Goossens JF; Colson P; Bailly C; Hénichart JP
J Med Chem; 2004 Jul; 47(14):3665-73. PubMed ID: 15214793
[TBL] [Abstract][Full Text] [Related]
13. Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
Parenty AD; Smith LV; Guthrie KM; Long DL; Plumb J; Brown R; Cronin L
J Med Chem; 2005 Jul; 48(14):4504-6. PubMed ID: 15999988
[TBL] [Abstract][Full Text] [Related]
14. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
[TBL] [Abstract][Full Text] [Related]
15. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of mono- and bisdihydrodipyridopyrazines and assessment of their DNA binding and cytotoxic properties.
Blanchard S; Rodriguez I; Tardy C; Baldeyrou B; Bailly C; Colson P; Houssier C; Léonce S; Kraus-Berthier L; Pfeiffer B; Renard P; Pierré A; Caubère P; Guillaumet G
J Med Chem; 2004 Feb; 47(4):978-87. PubMed ID: 14761199
[TBL] [Abstract][Full Text] [Related]
17. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents.
Alcaro S; Arena A; Neri S; Ottanà R; Ortuso F; Pavone B; Vigorita MG
Bioorg Med Chem; 2004 Apr; 12(7):1781-91. PubMed ID: 15028268
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
[TBL] [Abstract][Full Text] [Related]
20. Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
Ohara K; Smietana M; Restouin A; Mollard S; Borg JP; Collette Y; Vasseur JJ
J Med Chem; 2007 Dec; 50(26):6465-75. PubMed ID: 18052116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
